Explosive Growth

We’re at war! The West vs China. Call it a cold war, a trade war or a technology war. The label doesn’t matter. The world’s two largest economies are beating their chests. It’s a fight to see who’ll be top gorilla in the next decade. Neither side will go down without a fight. It might not escalate to missiles and bombs. The temperature could drop. But no boardroom in Washington, Berlin or Tokyo is betting the next decade on Beijing staying friendly. The lesson of the past three years has sunk in. You need your critical supply chains sitting outside China, or at minimum the ability to switch fast when the gate slams shut. Supply chain sovereignty is a must-have. We’ve watched the paranoia and resentment build over the last decade. It hit a tangible fever pitch as the Covid pandemic played out. Export licences on gallium and germanium. Restrictions on the heavy rare earths that go into magnets. Stockpiling programs from the Pentagon to the European Commission. Rare Earth Elements (REE) sit right at the centre of it. They’re the one chokepoint where China holds almost the entire chain.

Audeara (ASX:AUA) has hit the holy grail of high-growth ASX small-caps. Operating cash-flow positive.
…Just.
We’re talking $356 thousand.
We’re being a little bit cheeky here…

The decision window is here.
We first introduced Lumos Diagnostics (ASX:LDX) as a classic asymmetric healthcare setup. A proven test. A massive clinical need. One regulatory gate…

It’s is setting up as one of the most binary biotech plays on the ASX.
Timing is everything.
The company is running a late-stage Alzheimer’s trial with the interim analysis due…

Moving money has never been easier.

You tap. The screen flashes. Transaction complete.

It looks instant. It feels effortless.

But that three-second moment? Behind it sits an entire hidden universe. A chaotic tangle of identity checks, fraud scans, risk calculations, regulatory verifications, and settlement logic all firing in perfect sequence.

Let’s do a thought experiment. Imagine your eyesight’s starting to fade. You can still see fine at a distance, but now you’re holding books and your phone half a metre from your face just to make out the words. It’s the classic ‘old person’ move. If a movie director wants to show someone’s getting older, they don’t need wrinkles or a walking stick, they just show them squinting at a menu and holding it away like it’s radioactive.

The ASX Minnow Solving Medicine’s Big Dilemma
General advice only – prepared for Wholesale/Sophisticated/Professional Investors. See full disclaimers below.
Long before antibiotics, biotech, or even modern medicine, there was a king who feared one thing above all.

Mithridates VI of Pontus ruled in the first century BC. A time when assassination by poison was the equivalent of an election today.

His enemies were everywhere: inside his court, across his borders, even within his own family. Watching, plotting, scheming.

In January 1848, a carpenter named James Marshall was inspecting the sawmill he was building for Swiss emigrant John Sutter on the banks of the American River in California

Long before antibiotics, biotech, or even modern medicine, there was a king who feared one thing above all.
Mithridates VI of Pontus ruled in the first century BC. A time when assassination by poison was the equivalent of an election today.